The following Ambien side effects are the most common:
Approximately 4% of 1,701 patients who received Ambien at all doses (1.25 to 90 mg) in U.S. pre-marketing clinical trial discontinued treatment because of an adverse clinical event. Side effects most commonly associated with discontinuation from U.S. trials were daytime drowsiness (0.5%), dizziness (0.4%), headache (0.5%), nausea (0.6%), and vomiting (0.5%).
Approximately 6% of 1320 patients who received Ambien at all doses (5 to 50 mg) in similar European trials discontinued treatment because of a side effects. Events most commonly associated with discontinuation from these trials were daytime drowsiness (1.6%), amnesia (0.6%), dizziness (0.6%), headache (0.6%), nausea (0.6%).
There may be additional unreported Ambien side effects.
Buy Ambien